Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances Give Kids a Chance Act to accelerate pediatric rare disease treatments; PRV reauthorized
Summary
The House Energy and Commerce Committee voted to advance HR 1262, the Give Kids a Chance Act, reauthorizing the FDA rare pediatric disease priority review voucher program and other measures to speed pediatric cancer and rare disease research and access.
The House Energy and Commerce Committee voted to advance HR 1262, the Give Kids a Chance Act of 2025, reauthorizing the Food and Drug Administration's rare pediatric disease priority review voucher (PRV) program and adding authorities intended to accelerate pediatric cancer trials.
Representative Doris Matsui (D-Calif.), a co-leader on the measure, said the bill will "give kids a fighting chance," emphasizing that the PRV program has led to approvals for dozens of pediatric treatments since 2012. Representative Gus Bilirakis (R-Fla.), a…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
